Summary
Canada became the first G7 country to approve generic semaglutide in April 2026. Two generics — Apo-Semaglutide (Apotex) and Dr. Reddy's version — are now available at Canadian pharmacies at roughly $100–150/month, compared to $250–500 for brand-name Ozempic.
Two Generics Are Now Approved — Here's Who Made Them
Health Canada approved Dr. Reddy's Laboratories' generic semaglutide injection on April 28, 2026 — the first generic semaglutide ever approved in a G7 country. Just three days later, on May 1, 2026, Apotex (Canada's largest domestic pharmaceutical company) received approval for its product, branded as Apo-Semaglutide Injection. Both products launched commercially in mid-May 2026, with inventory shipping to wholesalers and expected on pharmacy shelves across Canada by late May 2026. Health Canada is currently reviewing eight additional generic submissions from manufacturers including Sandoz and Teva Canada, meaning further competition — and further price drops — are expected throughout 2026.
Key point: Canada is the first G7 country to approve generic semaglutide, giving Canadians early access to a dramatically cheaper version of one of the world's most prescribed medications.
How Much Does Generic Semaglutide Cost in Canada?
The price difference is substantial. Brand-name Ozempic currently costs $250 to $500+ per month in Canada depending on dose and pharmacy. With two generics now on the market, prices are expected to settle around $100 to $150 per month for a four-week supply. Under Canada's generic drug pricing framework, the maximum public drug plan price is approximately $114 per four-week supply with two generics approved. Apotex has stated its Apo-Semaglutide will be approximately one-third the price of brand-name Ozempic. As more generics receive approval and competition increases, prices are projected to fall further — potentially below $100/month for some plans. Check the weight-loss.ca Generic Semaglutide Tracker for the most current pricing by manufacturer.
Key point: Generic semaglutide is expected to cost $100–150/month — roughly one-third the price of brand-name Ozempic.
Critical Nuance: These Generics Are for Type 2 Diabetes, Not Weight Loss
This is the most important thing to understand. The generics approved so far are indicated for the treatment of Type 2 diabetes in adults — the same indication as Ozempic 1mg. They are NOT approved for chronic weight management, which requires the higher 2.4mg dose sold as Wegovy. That said, doctors in Canada already routinely prescribe Ozempic off-label for weight loss, and they can do the same with generic semaglutide. An off-label prescription is legal and common — your doctor simply writes a prescription for semaglutide and you fill it with the generic version. However, no generic equivalent of Wegovy (the 2.4mg weight loss formulation) has been approved yet. If you currently use Wegovy specifically, your options remain limited to the brand-name product for now.
Key point: Generic semaglutide is approved for Type 2 diabetes only. Off-label use for weight loss is possible but discuss it with your doctor.
Is Generic Semaglutide Bioequivalent to Ozempic?
Yes. Health Canada only approves generics that have demonstrated bioequivalence to the reference product — meaning they deliver the same active ingredient at the same dose, with the same absorption profile, as brand-name Ozempic. The injectable pen device and the cosmetic appearance of the product may differ between manufacturers, but the drug itself behaves identically in your body. Side effects, efficacy, and dosing schedules are the same. If you're switching from Ozempic to a generic, you do not need a new titration schedule — your current dose applies directly.
What Happens Next: More Generics Coming
Health Canada is actively reviewing submissions from at least eight more manufacturers. Each new generic that reaches the market increases price competition. Under Canadian generic pricing rules, prices step down as more generics enter: two generics trigger one price ceiling, three or more trigger a lower ceiling. Analysts expect monthly costs to fall to $80–120 once the market reaches three to five competing generics. This price compression is expected to happen through the second half of 2026. The weight-loss.ca Generic Semaglutide Tracker is updated weekly with every new Health Canada approval and price update.
🍁 What This Means for Canadians
Canada's role as the first G7 country to approve generic semaglutide is largely the result of Novo Nordisk failing to renew a CAD $250 government maintenance fee on a key patent, which caused it to lapse and opened the door for generic manufacturers. This is a rare case where a Canadian regulatory quirk produced a major patient benefit. Provincial drug plans are now working to update their formularies to include generic semaglutide, which could significantly expand access for low-income Canadians currently unable to afford brand-name Ozempic.
Track Every New Generic Semaglutide Approval in Canada
New generics are being approved regularly. Our Generic Semaglutide Canada Tracker is updated weekly with every Health Canada approval, current pricing, and pharmacy availability — so you always know your options.
Information on this page is for general informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making any healthcare decisions.